Pediatric transplantationHumansLiver TransplantationRetrospective StudiesImmunosuppressive AgentsSirolimus
Long Term Outcomes and Safety Profile of Sirolimus in Post Liver Transplant Children.
Sandra Fernandes Lucas, Suzan Warner, Penny North-Lewis, Marumbo Paul Mtegha, Kavitha Jayaprakash, Palaniswamy Karthikeyan, Sanjay Rajwal
Published: 202510.1111/petr.70235
Abstract
BACKGROUND: Tacrolimus is the maintenance immunosuppression of choice in pediatric liver transplant (LT) recipients. However, in selective cases, sirolimus is used as an alternative immunosuppressive treatment. We aimed to review a single centre's ex…
Preview only. Read the full abstract at the source